{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:18:21Z","timestamp":1777879101003,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007404","name":"China Medical University Hospital Taichung Hospital Clinical Trial Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007404","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jfma.2026.03.007","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:50:16Z","timestamp":1772715016000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Metabolic and liver stiffness measures for hepatocellular carcinoma risk stratification after viral eradication in chronic hepatitis C"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7110-4112","authenticated-orcid":false,"given":"Sheng-Hung","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsueh-Chou","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0738-417X","authenticated-orcid":false,"given":"Wei-Fan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6574-1561","authenticated-orcid":false,"given":"Hung-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9030-6086","authenticated-orcid":false,"given":"Cheng-Yuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2026.03.007_bib1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jhep.2021.09.007","article-title":"NAFLD-driven HCC: safety and efficacy of current and emerging treatment options","volume":"76","author":"Foerster","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2026.03.007_bib2","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2026.03.007_bib3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s13105-023-00954-4","article-title":"Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment","volume":"79","author":"Sangro","year":"2023","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.jfma.2026.03.007_bib4","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2026.03.007_bib5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/hepr.14011","article-title":"Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease","volume":"54","author":"Suzuki","year":"2024","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jfma.2026.03.007_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12072-023-10620-y","article-title":"Breaking new ground: MASLD vs. MAFLD-which holds the key for risk stratification?","volume":"18","author":"Ram\u00edrez-Mej\u00eda","year":"2024","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jfma.2026.03.007_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep4.1479","article-title":"Pathogenesis of nonalcoholic steatohepatitis: an overview","volume":"4","author":"Parthasarathy","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jfma.2026.03.007_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3748\/wjg.v28.i1.96","article-title":"Risk of hepatocellular carcinoma after hepatitis C virus cure","volume":"28","author":"Luna-Cuadros","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jfma.2026.03.007_bib9","doi-asserted-by":"crossref","first-page":"10175","DOI":"10.1002\/cam4.5711","article-title":"Hepatocellular carcinoma in patients cured of chronic hepatitis C: minimal steatosis","volume":"12","author":"Rocha","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.jfma.2026.03.007_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/MCG.0b013e3182a030c4","article-title":"The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis","volume":"48","author":"Jinjuvadia","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jfma.2026.03.007_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.808526","article-title":"Hepatocellular carcinoma and obesity, type 2 diabetes mellitus, cardiovascular disease: causing factors, molecular links, and treatment options","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Endocrinol"},{"issue":"Suppl","key":"10.1016\/j.jfma.2026.03.007_bib12","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","article-title":"MAFLD: how is it different from NAFLD?","volume":"29","author":"Gofton","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jfma.2026.03.007_bib13","article-title":"Differential prevalence and prognostic value of metabolic syndrome components among patients with MASLD","volume":"6","author":"Pustjens","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jfma.2026.03.007_bib14","first-page":"49","article-title":"Liver stiffness: a novel parameter for the diagnosis of liver disease","volume":"2","author":"Mueller","year":"2010","journal-title":"Hepat Med"},{"key":"10.1016\/j.jfma.2026.03.007_bib15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/cid\/ciz161","article-title":"Performance of acoustic radiation force impulse elastography for staging liver fibrosis in patients with chronic hepatitis C after viral eradication","volume":"70","author":"Chen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2026.03.007_bib16","first-page":"817","article-title":"Liver stiffness measurement can predict liver inflammation in chronic hepatitis B patients with normal alanine transaminase","volume":"11","author":"Huang","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jfma.2026.03.007_bib17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jhep.2019.10.005","article-title":"Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals","volume":"72","author":"Pons","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2026.03.007_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jhep.2024.03.015","article-title":"Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure","volume":"81","author":"Semmler","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2026.03.007_bib19","article-title":"An updated overview on hepatocellular carcinoma in patients with metabolic dysfunction-Associated steatotic liver disease: trends, pathophysiology and risk-based surveillance","volume":"162","author":"Armandi","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.jfma.2026.03.007_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"European association for the study of the liver. Electronic address: easlofficeeasloffice.eu; european association for the study of the liver. EASL clinical practice guidelines: management of alcohol-related liver disease","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2026.03.007_bib21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00535-023-02021-7","article-title":"MAFLD: an optimal framework for understanding liver cancer phenotypes","volume":"58","author":"Crane","year":"2023","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jfma.2026.03.007_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1244405","article-title":"Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease","volume":"14","author":"Semmler","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jfma.2026.03.007_bib23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2026.03.007_bib24","doi-asserted-by":"crossref","first-page":"844","DOI":"10.21037\/atm.2020.04.40","article-title":"Effects of primary hypertension treatment in the oncological outcomes of hepatocellular carcinoma","volume":"8","author":"Lopez-Lopez","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jfma.2026.03.007_bib25","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/liv.15577","article-title":"Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct-acting antivirals","volume":"43","author":"Pelusi","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.jfma.2026.03.007_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4093\/dmj.2020.0250","article-title":"Hyperinsulinemia in obesity, inflammation, and cancer","volume":"45","author":"Zhang","year":"2021","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.jfma.2026.03.007_bib27","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.3390\/ijms22105303","article-title":"Mechanisms of beta-cell apoptosis in type 2 diabetes-prone situations and potential protection by GLP-1-based therapies","volume":"22","author":"Costes","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jfma.2026.03.007_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","article-title":"How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?","volume":"15","author":"Geng","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jfma.2026.03.007_bib29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/cells9020461","article-title":"Cellular interplay as a consequence of inflammatory signals leading to liver fibrosis development","volume":"9","author":"Ignat","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jfma.2026.03.007_bib30","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/hep.30885","article-title":"Changes in hepatic venous pressure gradient predict hepatic decompensation in patients who achieved sustained virologic response to interferon-free therapy","volume":"71","author":"Mandorfer","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2026.03.007_bib31","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/cells8111419","article-title":"TGF-\u03b2 in hepatic stellate cell activation and liver fibrogenesis-updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jfma.2026.03.007_bib32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28450","article-title":"Physiological ranges of matrix rigidity modulate primary mouse hepatocyte function in part through hepatocyte nuclear factor 4 alpha","volume":"64","author":"Desai","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2026.03.007_bib33","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/jvh.13715","article-title":"Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver-related complications in patients with chronic hepatitis C receiving direct-acting antiviral agents","volume":"29","author":"Hsu","year":"2022","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jfma.2026.03.007_bib34","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jhep.2024.05.021","article-title":"Agile scores in MASLD and ALD: external validation and their utility in clinical algorithms","volume":"81","author":"Papatheodoridi","year":"2024","journal-title":"J Hepatol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664626001609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664626001609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:35:14Z","timestamp":1777592114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664626001609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":34,"alternative-id":["S0929664626001609"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2026.03.007","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic and liver stiffness measures for hepatocellular carcinoma risk stratification after viral eradication in chronic hepatitis C","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2026.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2026, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}